The Times of India, on 27th March 2010, reported that India has foiled a major bio-piracy bid on the use of Ashwagandha -- India's wonder plant in the treatment of a range of illnesses including depression, diabetes, insomnia, convulsions and gastritis.

On March 25, the European Patent Office (EPO) decided to withdraw American multinational company Natreon Inc's patent applications on the plant's medicinal properties after India submitted documented proof confirming how medicinal formulations using Ashwagandha were being used in India as far back as in the 12th century.

Called the Indian ginseng, Ashwagandha is used extensively in Ayurveda, Siddha and [...]

OUVRIR MON COMPTE CREATE MY ACCOUNT

  Un problème avec cet article ? / A problem with this article?